Leadership Overview
Nephron has 4 executives leading key functions including finance, marketing, administration, and clinical operations.
Driven by a commitment to accessible healthcare, Nephron manufactures essential generic respiratory medications, impacting patient well-being through reliable pharmaceutical solutions.
Driven by a commitment to accessible healthcare, Nephron manufactures essential generic respiratory medications, impacting patient well-being through reliable pharmaceutical solutions.
Leadership Roles at Nephron
Paul Koppang - Chief Financial Officer
Paul Koppang, the Chief Financial Officer at Nephron, directs all financial strategy and fiscal operations. Overseeing budgeting, forecasting, and financial reporting, the Chief Financial Officer ensures robust financial health for the organization. This leadership position involves managing capital allocation and driving profitability through efficient resource management. By optimizing financial processes, Paul Koppang directly supports Nephron's mission to provide affordable respiratory medications. Ultimately, Koppang secures long-term financial stability and growth for the company.
Timothy Antal - Chief Marketing Officer
Timothy Antal, the Chief Marketing Officer at Nephron, spearheads all marketing and brand strategy initiatives. Overseeing market analysis, product positioning, and promotional campaigns, the Chief Marketing Officer drives market penetration and brand awareness. This executive role involves developing go-to-market strategies and identifying new business opportunities within the pharmaceutical sector. By cultivating strong customer relationships and understanding market dynamics, Timothy Antal directly enhances Nephron's competitive edge. Ultimately, Antal ensures the effective communication of the company's value proposition to healthcare providers and patients.
Joe Mergo - Chief Administrative Officer
Joe Mergo, the Chief Administrative Officer at Nephron, manages all non-operational administrative functions and corporate services. Overseeing human resources, legal affairs, and facility management, the Chief Administrative Officer ensures seamless internal operations and compliance. This critical role involves optimizing organizational efficiency and fostering a productive work environment. By streamlining administrative processes and supporting departmental needs, Joe Mergo directly contributes to Nephron's operational excellence. Ultimately, Mergo provides the foundational support necessary for the company's manufacturing and distribution of essential medications.
Ashley Godwin - Clinical Assistant Professor
Ashley Godwin, the Clinical Assistant Professor at Nephron, contributes expertise in clinical practices and educational outreach. Overseeing the integration of clinical insights into product development and patient care strategies, the Clinical Assistant Professor bridges the gap between academic research and pharmaceutical application. This position involves advising on clinical efficacy and supporting educational initiatives for healthcare professionals. By ensuring that clinical perspectives inform company operations, Ashley Godwin directly enhances the quality and relevance of Nephron's respiratory medications. Ultimately, Godwin supports the company's commitment to advancing patient health through evidence-based solutions.
Explore Leadership Teams in Manufacturing
Founded in 2003, Phibro Animal Health Corporation is a global manufacturer and marketer of animal health pharmaceuticals, animal nutrition, and performance products. The company is headquartered in Teaneck, New Jersey.
Company Leadership
AS
GD
MG
Founded in 1947 and headquartered in Mumbai, Indoco Remedies Limited is a fully integrated, research-oriented pharma company. Indoco specializes in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
Company Leadership BD
PG
PA
Humanetics Corporation is a clinical-stage pharmaceutical company engaged in the accelerated discovery, development, and commercialization of proprietary drugs in markets with urgent and unmet needs with a focus on medical countermeasures, radiation modulators for oncology and inflammatory lung diseases.
Company Leadership CO
BL
BL
AS
Revolution Medicines Inc is a pioneering biotechnology company committed to revolutionizing treatment for patients battling cancer. They are driven by a singular mission: the discovery, development, and delivery of innovative, targeted medicines, particularly focusing on what are known as RAS-addicted cancers, which represent a significant proportion of new human cancer diagnoses. The company has developed a groundbreaking tri-complex inhibitor platform to create a portfolio of RAS(ON) inhibitors, enabling a differentiated approach to target what was previously considered an undruggable molecular target in oncology. Through their tireless efforts and commitment to transformative science, they are building a deep pipeline of therapeutic candidates intended to change the standard of care for patients with these challenging diseases.
Company Leadership AS
SK
Frequently Asked Questions Regarding Nephron Top Executives and Leadership Team
